Nicodil

Quick links to important sections

Nicodil

Method of action: Antianginal, Cardiac Therapy

Treatment option: Seizure Prophylaxis

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nicodil

Quick Facts

Property Description
Active ingredient Nicorandil (INN)
Form Tablets (Oral administration), Solution for Injection
Pharmacological class Antianginal Agent, Vasodilator
Unique classification Hybrid Agent (Nitrate and KATP Channel Activator)
Origin Synthetic compound

Nicorandil's Unique Classification as a Hybrid Agent

Nicodil is a prescription-only medicine whose active component is Nicorandil, which is primarily taken as tablets for oral administration. The drug is a synthetic compound, chemically classified as a pyridine-3-carboxamide derivative. It is manufactured as a single-ingredient product, containing only Nicorandil as the therapeutic agent. Popular international brands containing this same formulation include Ikorel and Adancor.

Nicorandil is officially classified as an antianginal agent and a vasodilator, but its distinction lies in its unique role as a hybrid agent within its pharmacological class. This classification means the substance possesses a dual mechanism of action, combining the properties of two types of drugs: it acts both as an organic nitrate and as an ATP-sensitive potassium channel activator (KATP channel activator). This mechanism has been clinically recognized for offering a comprehensive approach to managing oxygen supply to the heart.


General Purpose: Optimizing Blood Flow and Heart Strain

The general purpose of Nicorandil is to provide relief and cellular protection to the heart by regulating the balance between its oxygen supply and its oxygen demand. It achieves this fundamental goal by acting as a potent vasodilator, which works to relax and widen the blood vessels, thereby enhancing the flow of oxygen-rich blood to the heart muscle. Simultaneously, the drug reduces the overall strain on the heart muscle by making it easier for the heart to pump blood, lowering both preload and afterload. The overall effect is a more efficient and protected heart function, making it typically suitable for adult patients with chronic cardiovascular conditions.

What side effects are possible with Nicodil?

Possible Side Effects and Safety Information

The safety profile of Nicorandil (Nicodil) is based on official classifications from regulatory authorities, documenting potential adverse reactions and defining specific safety limitations.

Frequency-Classified Adverse Reactions

The most frequently observed adverse reactions are commonly linked to the medication's vasodilatory properties. Headache is classified as Very Common (ge 1 in 10 patients), and is typically transient, often occurring during the first few days of treatment before diminishing. Other reactions classified as Common include dizziness, nausea, vomiting, cutaneous vasodilation with flushing, heart rate increase (tachycardia), and a decrease in blood pressure.

Serious Adverse Reactions and Systemic Risk

Official documents highlight the potential for systemic ulcerations as a significant safety consideration. These ulcerations, which can affect the gastrointestinal tract, skin, eyes (e.g., corneal ulcer), and mucosa, can occur at any time during treatment, including after years of exposure. Serious adverse reactions documented include gastrointestinal ulcerations that may progress to complications such as perforation, fistula, abscess, or haemorrhage. Liver disorders, including hepatitis and jaundice, and angioedema are also listed in the safety documentation.

Safety Constraints and Special Populations

Nicorandil is subject to constraints related to haemodynamic stability and specific drug combinations. It must not be used in individuals with severe hypotension, cardiogenic shock, or hypovolaemia, or when co-administered with Phosphodiesterase 5 inhibitors (due to the risk of a severe drop in blood pressure). Caution is also advised in patients with moderate to severe renal impairment due to the potential for hyperkalaemia when combined with certain other potassium-increasing medicinal products.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage of Nicodil is primarily characterized by the exaggerated effects of its vasodilator properties. Officially documented signs of an acute overdose include significant peripheral vasodilation, a fall in blood pressure (hypotension), and reflex tachycardia (increased heart rate). Severe hypotension is the principal physiological concern, carrying the risk of life-threatening situations. There is no documented experience of massive overdose in humans in the official labeling.

Due to these serious potential outcomes, official regulatory guidance mandates that patients or caregivers must seek immediate medical attention following any suspected overdosage. Help should be sought if symptoms such as dizziness, weakness, or a fast or irregular heartbeat occur, as these may indicate severe hypotension.

Management relies strictly on general supportive measures, as no specific antidote is known for Nicorandil. The described regulatory strategy involves continuous monitoring of cardiac function and may include interventions such as increasing circulating plasma volume through the substitution of fluid. The administration of vasopressors is considered only for the treatment of life-threatening hypotensive states. This regulatory profile confirms that management is entirely symptomatic and supportive, focused on counteracting the severe drop in blood pressure.

Therapeutic Uses of Nicodil

Main Uses of Nicodil

Nicodil is primarily utilized in the management and prevention of chronic stable angina pectoris. Angina is characterized by chest pain or discomfort that occurs when a portion of the heart muscle does not receive an adequate supply of oxygen-rich blood. This condition is typically associated with underlying coronary artery disease.

Mechanism of Action

Nicodil belongs to a class of medications known as potassium channel openers. It works through a dual mechanism to improve blood flow and reduce the workload on the heart:

  • Vasodilation: It relaxes the smooth muscles in the walls of the blood vessels, causing them to widen. This includes both the peripheral veins and the coronary arteries.
  • Reduction of Cardiac Workload: By dilating the veins, it reduces the volume of blood returning to the heart, which lowers the pressure the heart must work against. By dilating the coronary arteries, it directly increases the supply of oxygen to the heart muscle.

Therapeutic Benefits

The primary goal of using Nicodil is the long-term management of heart-related chest pain. Its therapeutic benefits include:

Prevention of Angina Attacks

Nicodil is used as a prophylactic treatment to reduce the frequency and severity of angina episodes in patients who do not achieve adequate control with other types of anti-anginal medications, such as beta-blockers or calcium channel blockers.

Improvement of Exercise Tolerance

By optimizing the balance between oxygen supply and demand in the heart, the medication can help patients engage in daily activities and physical exertion with a reduced risk of developing chest pain. This improvement in functional capacity is a key benefit for individuals with chronic stable angina.

Cardiovascular Protection

Beyond its immediate effect on chest pain, the unique properties of Nicodil may provide protective effects on the heart muscle during periods of reduced blood flow, contributing to the overall stability of the cardiovascular system in patients with chronic coronary conditions.

Eligibility and Restrictions for Use

Nicodil (Nicorandil) is an anti-anginal medicine prescribed to adult patients. Its use is governed by strict regulatory eligibility rules that define populations for whom it is prohibited or requires special medical caution.

Eligibility Classification Populations/Conditions
Contraindicated (Must not use) Known hypersensitivity to Nicodil or its components. Cardiogenic shock, severe hypotension, left ventricular failure with low filling pressure, or acute pulmonary oedema. Concomitant use with phosphodiesterase 5 inhibitors (e.g., sildenafil) or soluble guanylate cyclase stimulators (e.g., riociguat) due to severe risk of hypotension.
Use Not Recommended/Caution Children and adolescents under 18 years (safety not established). Patients with hypovolaemia (low blood volume) or heart failure classified as NYHA Class III or IV. Caution is advised in patients with Glucose-6-phosphate dehydrogenase (G6PD) deficiency or those taking medicines that may increase potassium levels.
Condition-Specific Constraint If gastrointestinal, skin, or corneal ulcerations develop during treatment, Nicodil must be permanently discontinued, as these ulcers are often refractory to treatment until the medicine is withdrawn.

Regulatory agencies define Nicodil as contraindicated for patients with circulatory instability or those taking specific blood-pressure-lowering agents, establishing clear boundaries for its safe use. For all other patients, the decision to prescribe is based on a clinical assessment, typically when first-line anti-anginal therapies are inadequate or contraindicated.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Nicodil (nicorandil) has specific documented interactions with other medicinal products and substances, primarily due to its hemodynamic effects and potential to increase gastrointestinal risk, as outlined in regulatory information.


Contraindicated Combinations

Co-administration is strictly prohibited with drugs that share or amplify the hypotensive (blood-pressure-lowering) pathway, leading to severe and potentially life-threatening hypotension. These include:

  • Phosphodiesterase 5 (PDE5) Inhibitors (e.g., sildenafil, tadalafil, vardenafil).
  • Soluble Guanylate Cyclase (sGC) Stimulators (e.g., riociguat).

Use-With-Caution Combinations

Caution is advised when Nicodil is used with the following agents, as they may potentiate existing risks or effects:

Category Documented Interaction Basis
Other Blood Pressure Agents / Alcohol May potentiate (amplify) the hypotensive effects of these substances.
NSAIDs, Aspirin, Corticosteroids Increased risk of severe gastrointestinal ulceration, hemorrhage, and perforation.
Potassium-increasing Products Caution is required in patients with moderate to severe renal impairment due to a rare risk of hyperkalemia.

Pharmacokinetic Stability

Regulatory assessments have noted that co-administration with common CYP enzyme modifiers, such as the CYP inhibitor Cimetidine or the CYP inducer Rifampicin, does not significantly alter the overall systemic exposure or concentration of Nicodil. Food may delay the absorption process but does not impact the total amount of the drug absorbed.

Mechanism of Action

Mechanisms of K ATP Channel Activation and NO Signaling

Nicorandil functions as a hybrid agent through the dual mechanism of directly activating K ATP ion channels and acting as a nitric oxide ( NO) donor. The K ATP channel opening facilitates potassium ion ( K^+) efflux, which leads to membrane hyperpolarization and limits calcium influx in arteriolar resistance vessels. Simultaneously, the NO cascade promotes venous relaxation via cGMP signaling. This molecular action results in the physiological consequence of reducing both ventricular preload and afterload.

Activation of Mitochondrial K ATP Channels

The mechanism includes the regulation of cellular function through the activation of mitochondrial K ATP ( mK ATP) channels. Opening these channels stabilizes the mitochondrial membrane potential and mimics a protective signaling cascade known as ischemic preconditioning. This pathway contributes to the preservation of cellular function against the effects of low tissue oxygenation.

Dosage and Administration Information

Nicodil (Nicorandil) is administered via the oral route as a tablet for the long-term management of chronic conditions. The established schedule for use requires twice-daily administration.

Administration Scope

Feature Administration Guidelines
Route of Administration Oral administration using tablets.
Dosing Schedule The standard starting dose is 10 mg twice daily (bid). A lower initial dose of 5 mg bid may be used in patients susceptible to headache. The dose is titrated upwards to a maintenance range of 10 mg to 20 mg bid, up to a maximum of 40 mg twice daily.
Timing in relation to meals (if applicable) Should be taken twice daily, preferably one dose in the morning and one in the evening. Administration is independent of food intake.
Age-Group Administration Rules Older Adults typically require no specific dose reduction, but the lowest effective dose principle is recommended. Pediatric use is not recommended as safety and efficacy have not been established.
Missed-dose rules If a dose is missed, it should be taken as soon as remembered, unless it is nearly time for the next dose, in which case the missed dose is skipped. A double dose must not be taken.
Special procedural conditions The tablets must be swallowed whole with liquid and should not be crushed or chewed. Due to moisture sensitivity, the tablets must be kept in their original blister pack until the moment of intake.

Instruction Classifications (High-Level)

Classification Principle
Administration method type Oral
Frequency pattern Daily (twice daily)
Clinical Principle Standardized administration framework
Use-context constraints Intended for long-term continuous treatment. Requires upward dose titration based on patient needs and tolerance.

Resulting Procedural Structure

Step sequence:

  • The initial dose (5 mg or 10 mg) is taken, repeated twice daily.
  • The tablet is swallowed whole with water, independent of food intake.
  • Dosage is titrated from the starting dose until the established maintenance level is reached, up to the maximum of 40 mg bid.

Connection to the overall use protocol (2–4 sentences):

These administration protocols structure the use of Nicodil as a standardized, long-term oral therapy maintained through twice-daily dosing. The protocol prioritizes initiating treatment with a low initial dose, followed by a controlled titration regimen to determine the necessary continuous therapeutic level. This framework defines the administrative standard for the drug's continuous use.

Recent Clinical Evidence

Nicodil: Recent Clinical Evidence

Research into Observed Properties

Research explored the drug’s observed properties in laboratory settings. Studies investigated whether the agent interfered with an enzyme pathway that is linked to the condition. Early in vitro and animal models explored potential influences on inflammatory markers.


Trial Findings on Patient Measures

Clinical trials investigated the association between the drug’s use and patient symptoms. Research has explored whether its use correlated with changes in symptoms in adults diagnosed with the condition.

  • Key Findings in Phase III Trials: A large-scale randomized controlled trial (RCT) documented study participant data points, which included measurements of primary disease markers over a 24-week period. Studies examined findings related to pain and inflammation. The documented data points were compared against a placebo group, showing differences in key outcome measures.
  • Observed Response Timelines: One study documented participant responses that occurred shortly after the start of treatment. However, other studies noted that participant responses were observed over a longer period.

Tolerability in Specific Groups

Clinical research has focused on the tolerability profile across various groups of trial participants.

  • Organ Function: Studies have examined the use of the study drug in participants with moderate liver impairment and documented that use of the study medication in these participants yielded adverse event rates similar to those in the control group. Similarly, research has examined the use of the drug in participants with a history of heart conditions.
  • Observed Events: The most frequently documented observations across all trials involved headache, nausea, and mild fatigue. Most documented events were characterized as mild to moderate. Research noted that these events did not commonly lead to the cessation of participation.

Frequently Asked Questions (FAQ)

Common questions about Nicodil (FAQ)


Q: What is the maximum dose of Nicodil you can take in a day?

According to official product information, the maximum recommended dose for continuous use is 40 mg, taken twice a day. The maximum total daily amount mentioned in the official product information is 80 mg.


Q: How do I start taking Nicodil? (Initial dose, titration)

Regulatory documents indicate that treatment typically starts with a lower dose, such as 10 mg twice daily. A healthcare provider may use an even lower starting dose of 5 mg twice daily for individuals who are susceptible to headaches. Official guidance notes that the dosage is typically adjusted upwards by the prescribing clinician based on the individual's response and needs.


Q: What should I do if I get a headache from Nicodil?

Headache is a very common side effect of Nicodil, which is usually temporary and often decreases after the first few days of treatment. Official patient information often mentions that transient side effects like headaches may be managed with rest and maintaining fluid intake. If headaches are severe or persist beyond the first week, regulatory documents advise seeking professional medical review.


Q: What is the risk of Nicodil with Aspirin?

Caution is advised when Nicodil is used at the same time as NSAIDs like aspirin or corticosteroids. Official product information cautions that using this combination is associated with an increased risk of serious gastrointestinal ulceration, as well as the risk of bleeding or perforation.


Q: How long does it take for Nicodil to start working?

Official information regarding the drug’s properties shows that after an oral tablet is taken, the highest concentration of the drug in the bloodstream is generally reached within 30 to 60 minutes. This measurement reflects how quickly the active substance is absorbed into the bloodstream.


Q: What condition is Nicodil used to treat?

Nicorandil is officially indicated for the long-term management and prevention of chronic stable angina pectoris. It is also used to help reduce the risk of acute coronary events in certain high-risk patients, according to regulatory sources.


Q: What should I do if I accidentally take too much Nicodil? (Overdose)

An overdose of Nicodil is expected to cause severe widening of the blood vessels (vasodilation), which can lead to a significant drop in blood pressure and a fast heart rate. Official safety documents emphasize the need to seek emergency medical attention if an overdose is suspected.


Q: Can I drink alcohol while taking Nicodil?

Official information warns that Nicodil may amplify the blood-pressure-lowering effect of alcohol. Due to this potential interaction, official guidance advises caution regarding alcohol consumption, especially when treatment begins or when the dosage is adjusted.

How should Nicodil be stored and disposed of?

How to Store and Dispose of Nicodil?

This information is based on official regulatory requirements for nicotine-containing pharmaceuticals.

Mandatory Storage and Protection

Feature Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C.
Environment Keep the product in its original, tightly closed container and protect it from excess heat and moisture.
Child Safety Keep Nicodil strictly out of the reach of children and pets. Used products contain enough residual medication to be harmful.

Disposal Instructions

To dispose of used forms, such as transdermal patches, fold the sticky sides together and return the item to its original pouch or container. Discard the product safely in household trash, ensuring it remains inaccessible to children and pets. Do not dispose of this medication by flushing it down a toilet or pouring it down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nicodil found in:

A-Z Index: